Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

Cardinal Tightens Customer Pricing Due To Manufacturer Inventory Policies

  • News

Executive Summary

Drug manufacturer restrictions on wholesaler stocking in advance of price increases are causing Cardinal to offer less favorable contracts to customers, the company told its investor conference Aug. 12 in New York City

You may also be interested in...



McKesson/VA Contract Is Cost-5%; “Irresponsible,” Amerisource Says

McKesson will be providing wholesale distribution services to the Department of Veterans Affairs at cost minus 5%

McKesson/VA Contract Is Cost-5%; “Irresponsible,” Amerisource Says

McKesson will be providing wholesale distribution services to the Department of Veterans Affairs at cost minus 5%

McKesson Takes VA Contract From Amerisource, Cites Technology As Reason

McKesson's automated ordering technology is one reason the wholesaler won the Veterans Affairs prime vendor contract from the incumbent AmerisourceBergen, McKesson said Dec. 31

Table

View full table

Related Content

Pink Sheet
Pink Sheet
Pink Sheet
Tags:
Latest Headlines

Global Pharma Guidance Tracker – March 2024

EU Stakeholders Devise Six-Point Plan To Improve Cross-Border Clinical Trials

Japan Regulatory Update: Revised Law Widens RWD Scope, Price Revisions/Listings

China’s Public Payer Wants To Define Innovative Drugs As Those With ‘Novel Benefits’

See All
UsernamePublicRestriction

Register

PS042313

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By